Gilead Sciences, Inc.

NASDAQ:GILD   3:59:58 PM EDT
68.29
-1.54 (-2.20%)
4:04:47 PM EDT: $68.26 -0.03 (-0.04%)
Products

Gilead Submits NDA To U.S. FDA For Lenacapavir

Published: 06/28/2021 21:00 GMT
Gilead Sciences, Inc. (GILD) - Gilead Submits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-acting Capsid Inhibitor for the Treatment of Hiv-1 in People With Limited Therapy Options.
Gilead Sciences - Plans to Submit Marketing Authorization Applications for Lenacapavir to Ema and Other Global Agencies in Coming Months.